HTA59 Anticipating Market Access Challenges in Canada for Lecanemab: Learnings from Previous Health Technology Assessments of Disease-Modifying Therapies in Neurodegenerative Diseases
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1488
https://www.valueinhealthjournal.com/article/S1098-3015(23)01588-7/fulltext
Title :
HTA59 Anticipating Market Access Challenges in Canada for Lecanemab: Learnings from Previous Health Technology Assessments of Disease-Modifying Therapies in Neurodegenerative Diseases
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01588-7&doi=10.1016/j.jval.2023.03.1488
First page :
Section Title :
Open access? :
No
Section Order :
10890